Di Wu
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma Melanoma | Phase 2 | 2021-07-15 |
| Recruiting | Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma Acral Melanoma | Phase 2 | 2021-03-01 |
| Unknown | Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Soft Tissue Sarcomas, Undifferentiated Pleomorphic Sarcoma | Phase 2 | 2019-07-19 |